The MarketWatch News Department was not involved in the creation of this content. Cambridge-based surgical robotics company contributes majority of surgical data to world's largest open healthcare ...
Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U ...
CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
CMR Surgical is launching a new imaging technology to help users of its Versius robot visualize the flow of blood through organs during a procedure. The company’s vLimeLite add-on incorporates a ...
Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...
A market stall holder has praised robot-assisted surgery for helping her get back to her customers sooner. Charlotte Gregersen, 62, underwent thoracic surgery at Royal Papworth Hospital in Cambridge ...
The U.S. FDA recently cleared Medtronic plc’s Hugo robotic-assisted surgery system and CMR Surgical Ltd.’s Versius Plus system, adding new options to the U.S. market to meet rising demand for robotic ...
Oct 15 (Reuters) - UK-based medical device maker CMR Surgical said on Tuesday that the U.S. Food and Drug Administration has cleared the upgraded version of its surgical robot to be used in gall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results